A biotech ETF, a cash-gushing large-cap, and a dirt-cheap biopharma company top our list of great stocks to buy right now.
News & Analysis: SPDR S&P Biotech
These exchange-traded funds could deliver outsize gains in the years ahead.
Investing in biotechnology has been very lucrative lately, and these funds can help you tap into the industry's success.
It comes down to risk vs. reward.
Find out how to separate the best ETFs from the rest.
Not all biotech ETFs are alike. Here are the top 3 for investors to consider.
Exposing your portfolio to high-growth industries while staying diversified is a way to boost your portfolio with less risk.
Biotech stocks come roaring back to life.
It was a terrific week to be a healthcare investor, but the performance of this one ETF was simply outstanding.
Biotech stocks got kicked in the teeth on Wednesday, with Bluebird getting hit hard than most.